Cimzia gets FDA approval for psoriatic arhtritis

[Fred]

Cimzia (certolizumab pegol) has been given FDA approval for the treatment of Psoriatic Arthritis (PsA) in adults.

Important Safety Information You Should Know About CIMZIA® (certolizumab pegol) can be found on their [web]https://www.cimzia.com/psoriatic-arthritis/[/web]

Other posts about Cimzia:
UCB announces filings for Cimzia to treat PsA
UCB's Cimzia for psoriatic arthritis Phase 3 results
Certolizumab Pegol and Psoriatic Arhtritis study results

[Fred]

UPDATE: Cimzia (certolizumab pegol) has been launched this week for the treatment of Psoriatic Arthritis (PsA) for adults in the UK and Ireland.

[Fred]

Update: The FDA has approved extending the label for Cimzia (certolizumab pegol) to include a new indication in adults with moderate-to-severe plaque psoriasis.